Daniel Zabrowski

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA.

Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA.

Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA.

Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA.

Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.